• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于低分子量肝素涂层和树状大分子的核壳纳米平台,具有增强的免疫激活和多种抗转移作用,用于黑色素瘤治疗。

Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment.

机构信息

Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, China.

出版信息

Theranostics. 2019 Jan 1;9(2):337-354. doi: 10.7150/thno.29026. eCollection 2019.

DOI:10.7150/thno.29026
PMID:30809278
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6376190/
Abstract

High-efficiency treatment for tumor is not easy to achieve owing to the existence of metastasis, which remains the arch-criminal of most tumor deaths. Conventional chemotherapy exhibits insufficient inhibitory efficiency on tumor metastasis and more powerful strategies to conquer metastatic tumors are urgently needed. In this study, a rational chemoimmunotherapy strategy was adopted to treat highly aggressive melanoma based on a newly developed multifunctional nanoplatform. Firstly, immunoadjuvant cytosine-phosphate-guanine oligonucleotides (CpG ODNs) were used to boost the doxorubicin (DOX)-elicited immune responses, which synergistically suppressed tumor growth and metastasis. And the anti-metastatic low molecular weight heparin (LMWH) was also integrated, thus multiple anti-metastatic effects to against tumor metastasis were achieved. G4 PAMAM was serving as the main support to conjugate DOX by pH-sensitive hydrazone bond (PPD) and the synthesized conjugates were confirmed by H-NMR spectra, IR spectra and HRMS. Immunoadjuvant CpG ODNs were loaded by electrostatic adsorption to formulate PPD/CpG. After the coating of anti-metastatic LMWH, the designed LMWH/PPD/CpG was fabricated and characterized. The platelets-related and platelets-unrelated anti-metastatic mechanisms were investigated on B16F10 the immune activation effects, anti-tumor and anti-metastatic efficacy of LMWH/PPD/CpG were evaluated on a B16F10 melanoma xenograft model. DOX elicited tumor-specific immune responses by ICD, and the immunological effects could be further promoted by CpG ODNs, exhibiting enhanced maturation of dendritic cells (DCs) and increased level of cytolytic T lymphocytes (CTLs) . Owing to the coating of LMWH, the platelets-induced epithelial-mesenchymal-like transition of tumor cells was hindered and the actin cytoskeletal arrangement of tumor cells was affected, thus the migration ability of tumor cells was further inhibited. This multifunctional nanoplatform showed enhanced treatment efficiency on melanoma primary tumor and pulmonary metastasis. The immune activation and multiple anti-metastatic effects of LMWH/PPD/CpG establish a novel therapeutic strategy for melanoma. This anti-metastatic nanoplatform could be broadly applied for the co-delivery of other nucleic acids and chemotherapeutic drugs to treat highly aggressive tumors.

摘要

高效治疗肿瘤并不容易,因为转移的存在,这仍然是大多数肿瘤死亡的罪魁祸首。传统的化疗对肿瘤转移的抑制效率不足,迫切需要更强大的策略来攻克转移性肿瘤。在这项研究中,基于新开发的多功能纳米平台,采用合理的化学生物免疫治疗策略来治疗高度侵袭性黑色素瘤。首先,使用免疫佐剂胞嘧啶-磷酸-鸟嘌呤寡核苷酸(CpG ODNs)来增强阿霉素(DOX)引起的免疫反应,从而协同抑制肿瘤生长和转移。并且还整合了抗转移低分子量肝素(LMWH),从而实现了多种抗转移作用来对抗肿瘤转移。G4 PAMAM 作为通过 pH 敏感腙键(PPD)连接 DOX 的主要支撑物,通过 H-NMR 光谱、IR 光谱和 HRMS 来确认合成的缀合物。通过静电吸附装载免疫佐剂 CpG ODNs 以形成 PPD/CpG。在涂覆抗转移 LMWH 后,制备并表征了设计的 LMWH/PPD/CpG。在 B16F10 黑色素瘤异种移植模型上评估了 LMWH/PPD/CpG 的血小板相关和血小板无关的抗转移机制、免疫激活作用、抗肿瘤和抗转移疗效。DOX 通过 ICD 引起肿瘤特异性免疫反应,CpG ODNs 可进一步促进免疫反应,表现为树突状细胞(DCs)成熟增强,细胞毒性 T 淋巴细胞(CTLs)水平升高。由于 LMWH 的涂层,血小板诱导的肿瘤细胞上皮-间充质样转化受到阻碍,肿瘤细胞的肌动蛋白细胞骨架排列受到影响,从而进一步抑制了肿瘤细胞的迁移能力。这种多功能纳米平台对黑色素瘤原发肿瘤和肺转移显示出增强的治疗效果。LMWH/PPD/CpG 的免疫激活和多种抗转移作用为黑色素瘤建立了一种新的治疗策略。这种抗转移纳米平台可广泛应用于其他核酸和化疗药物的共递送,以治疗高度侵袭性肿瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/8a3c706020e3/thnov09p0337g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/540ce938717f/thnov09p0337g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/175748ffab94/thnov09p0337g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/c9d987c54408/thnov09p0337g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/c3fe32f20066/thnov09p0337g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/48a9bda719d0/thnov09p0337g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/30a8c388c408/thnov09p0337g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/4f5fa48b9f3e/thnov09p0337g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/37512ce6348b/thnov09p0337g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/8a3c706020e3/thnov09p0337g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/540ce938717f/thnov09p0337g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/175748ffab94/thnov09p0337g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/c9d987c54408/thnov09p0337g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/c3fe32f20066/thnov09p0337g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/48a9bda719d0/thnov09p0337g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/30a8c388c408/thnov09p0337g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/4f5fa48b9f3e/thnov09p0337g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/37512ce6348b/thnov09p0337g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/98eb/6376190/8a3c706020e3/thnov09p0337g009.jpg

相似文献

1
Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment.基于低分子量肝素涂层和树状大分子的核壳纳米平台,具有增强的免疫激活和多种抗转移作用,用于黑色素瘤治疗。
Theranostics. 2019 Jan 1;9(2):337-354. doi: 10.7150/thno.29026. eCollection 2019.
2
A low-molecular-weight heparin-coated doxorubicin-liposome for the prevention of melanoma metastasis.一种用于预防黑色素瘤转移的低分子量肝素包被阿霉素脂质体。
J Drug Target. 2015 May;23(4):335-46. doi: 10.3109/1061186X.2014.996760. Epub 2014 Dec 26.
3
Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.基于聚多巴胺的纳米平台用于光热消融,具有长期免疫激活作用,可对抗黑色素瘤及其复发。
Acta Biomater. 2021 Dec;136:546-557. doi: 10.1016/j.actbio.2021.09.014. Epub 2021 Sep 16.
4
Co-delivery of doxorubicin and epacadostat via heparin coated pH-sensitive liposomes to suppress the lung metastasis of melanoma.肝素包覆 pH 敏感脂质体共递送多柔比星和依帕司他以抑制黑色素瘤肺转移。
Int J Pharm. 2020 Jun 30;584:119446. doi: 10.1016/j.ijpharm.2020.119446. Epub 2020 May 18.
5
Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.用具有抗血管生成和抗癌作用的低分子量肝素衍生物修饰还原氧化石墨烯纳米片递药系统用于抗癌药物的输送。
J Control Release. 2014 Sep 10;189:80-9. doi: 10.1016/j.jconrel.2014.06.026. Epub 2014 Jun 26.
6
Low molecular weight heparin modified bone targeting liposomes for orthotopic osteosarcoma and breast cancer bone metastatic tumors.低分子量肝素修饰骨靶向脂质体治疗骨肉瘤和乳腺癌骨转移瘤。
Int J Biol Macromol. 2020 Dec 1;164:2583-2597. doi: 10.1016/j.ijbiomac.2020.08.068. Epub 2020 Aug 11.
7
Low molecular weight heparin-based reduction-sensitive nanoparticles for antitumor and anti-metastasis of orthotopic breast cancer.基于低分子量肝素的还原敏感纳米粒用于治疗原位乳腺癌的抗肿瘤和抗转移。
Biomater Sci. 2018 Jul 24;6(8):2172-2188. doi: 10.1039/c8bm00486b.
8
ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.基于氧化锌的多功能纳米复合材料通过诱导免疫原性细胞死亡引发抗肿瘤免疫来抑制黑色素瘤的进展和转移。
Theranostics. 2020 Sep 14;10(24):11197-11214. doi: 10.7150/thno.44920. eCollection 2020.
9
Antitumor and Antimetastasis Activities of Heparin-based Micelle Served As Both Carrier and Drug.兼具载体和药物功能的肝素基胶束的抗肿瘤和抗转移活性
ACS Appl Mater Interfaces. 2016 Apr 20;8(15):9577-89. doi: 10.1021/acsami.5b12347. Epub 2016 Apr 8.
10
Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment.聚合物-药物纳米颗粒结合阿霉素载体与肝素生物活性功能用于原发性和转移性癌症治疗。
Mol Pharm. 2017 Feb 6;14(2):513-522. doi: 10.1021/acs.molpharmaceut.6b00979. Epub 2017 Jan 17.

引用本文的文献

1
Nanotechnology in leukemia therapy: revolutionizing targeted drug delivery and immune modulation.白血病治疗中的纳米技术:革新靶向药物递送与免疫调节
Clin Exp Med. 2025 May 17;25(1):166. doi: 10.1007/s10238-025-01686-z.
2
Immunotherapy and delivery systems for melanoma.黑素瘤的免疫疗法和递药系统。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2394252. doi: 10.1080/21645515.2024.2394252. Epub 2024 Sep 17.
3
Nanotechnology as a Promising Method in the Treatment of Skin Cancer.纳米技术作为治疗皮肤癌的有前途的方法。

本文引用的文献

1
Nanoparticle-Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy.纳米颗粒介导的免疫原性细胞死亡使癌症免疫治疗成为可能并增强其疗效。
Angew Chem Int Ed Engl. 2019 Jan 14;58(3):670-680. doi: 10.1002/anie.201804882. Epub 2018 Nov 15.
2
Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer.联合 Rho-kinase 抑制和免疫原性细胞死亡触发并传播对癌症的免疫。
Nat Commun. 2018 Jun 4;9(1):2165. doi: 10.1038/s41467-018-04607-9.
3
Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma.
Int J Mol Sci. 2024 Feb 10;25(4):2165. doi: 10.3390/ijms25042165.
4
Cellular-Membrane-Derived Vesicles for Cancer Immunotherapy.用于癌症免疫治疗的细胞膜衍生囊泡
Pharmaceutics. 2023 Dec 22;16(1):22. doi: 10.3390/pharmaceutics16010022.
5
Tumor microenvironment-responsive spherical nucleic acid nanoparticles for enhanced chemo-immunotherapy.肿瘤微环境响应性球形核酸纳米粒子用于增强化学免疫治疗。
J Nanobiotechnology. 2023 May 26;21(1):171. doi: 10.1186/s12951-023-01916-0.
6
Heparin Mimetics and Their Impact on Extracellular Matrix Protein Assemblies.肝素模拟物及其对细胞外基质蛋白组装的影响。
Pharmaceuticals (Basel). 2023 Mar 22;16(3):471. doi: 10.3390/ph16030471.
7
Advancements in nanoparticle-based treatment approaches for skin cancer therapy.基于纳米粒子的皮肤癌治疗方法的进展。
Mol Cancer. 2023 Jan 12;22(1):10. doi: 10.1186/s12943-022-01708-4.
8
Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy.细胞膜衍生囊泡:一种用于癌症免疫治疗的新型载体。
Front Immunol. 2022 Jul 7;13:923598. doi: 10.3389/fimmu.2022.923598. eCollection 2022.
9
pH-Responsive Polymer Nanomaterials for Tumor Therapy.用于肿瘤治疗的pH响应性聚合物纳米材料
Front Oncol. 2022 Mar 22;12:855019. doi: 10.3389/fonc.2022.855019. eCollection 2022.
10
Doxorubicin and CpG loaded liposomal spherical nucleic acid for enhanced Cancer treatment.阿霉素和 CpG 负载的脂质体球形核酸增强癌症治疗。
J Nanobiotechnology. 2022 Mar 18;20(1):140. doi: 10.1186/s12951-022-01353-5.
纳米颗粒介导的 Wnt 家族成员 5A 在肿瘤微环境中的捕获增强了 B-Raf 原癌基因突变型黑色素瘤的免疫治疗。
ACS Nano. 2018 Feb 27;12(2):1250-1261. doi: 10.1021/acsnano.7b07384. Epub 2018 Jan 31.
4
Nanoplatform Assembled from a CD44-Targeted Prodrug and Smart Liposomes for Dual Targeting of Tumor Microenvironment and Cancer Cells.由 CD44 靶向前药和智能脂质体组装的纳米平台用于肿瘤微环境和癌细胞的双重靶向。
ACS Nano. 2018 Feb 27;12(2):1519-1536. doi: 10.1021/acsnano.7b08051. Epub 2018 Jan 24.
5
Targeting neoantigens to augment antitumour immunity.靶向新抗原以增强抗肿瘤免疫力。
Nat Rev Cancer. 2017 Apr;17(4):209-222. doi: 10.1038/nrc.2016.154. Epub 2017 Feb 24.
6
Polymer-Drug Nanoparticles Combine Doxorubicin Carrier and Heparin Bioactivity Functionalities for Primary and Metastatic Cancer Treatment.聚合物-药物纳米颗粒结合阿霉素载体与肝素生物活性功能用于原发性和转移性癌症治疗。
Mol Pharm. 2017 Feb 6;14(2):513-522. doi: 10.1021/acs.molpharmaceut.6b00979. Epub 2017 Jan 17.
7
Antitumor and Antimetastasis Activities of Heparin-based Micelle Served As Both Carrier and Drug.兼具载体和药物功能的肝素基胶束的抗肿瘤和抗转移活性
ACS Appl Mater Interfaces. 2016 Apr 20;8(15):9577-89. doi: 10.1021/acsami.5b12347. Epub 2016 Apr 8.
8
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.常规化疗和靶向抗癌药物的免疫效应。
Cancer Cell. 2015 Dec 14;28(6):690-714. doi: 10.1016/j.ccell.2015.10.012.
9
Passivation Using Molecular Halides Increases Quantum Dot Solar Cell Performance.使用分子卤化物进行钝化可提高量子点太阳能电池的性能。
Adv Mater. 2016 Jan 13;28(2):299-304. doi: 10.1002/adma.201503657. Epub 2015 Nov 18.
10
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.上皮-间质转化并非肺转移所必需,但会导致化疗耐药。
Nature. 2015 Nov 26;527(7579):472-6. doi: 10.1038/nature15748. Epub 2015 Nov 11.